Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of Schizophrenia and Related Disorders in Children and Adolescents

Trial Profile

Treatment of Schizophrenia and Related Disorders in Children and Adolescents

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2018

At a glance

  • Drugs Molindone (Primary) ; Olanzapine (Primary) ; Risperidone (Primary)
  • Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms TEOSS
  • Most Recent Events

    • 01 Jun 2010 Results from the 44-week double-blind extension phase have been published in the Journal of the American Academy of Child & Adolescent Psychiatry.
    • 09 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top